Results 201 to 210 of about 16,378 (224)

Data Sheet 1_Immunotherapy for neuromyelitis optica spectrum disorder: a comparative analysis of efficacy and safety of azathioprine, mycophenolate mofetil, tacrolimus, and rituximab.pdf

Jing Zhou (168494), Xiaolin Yang (276496), Xinyi Wang (559030), Bin Li (39349), Yun Xu (139234), Haoran Zhang (731854), Yinxin Zhu (16801349), Xiaoming Wang (187053), Jinzhou Feng (642562)   +8 more
openalex   +1 more source

B cell receptor repertoire reconstitution in patients with neuromyelitis optica spectrum disorder receiving B-cell depletion therapy. [PDF]

Front Immunol
Kim HJ, Shin W, Seo D, Jang I, Ryu J, Choi L, Kim J, Kim H, Lim YM, Lee EJ.   +9 more
europepmc   +1 more source

A Chinese girl with neuromyelitis optica spectrum disorder coexisting with primary Sjogren's syndrome: a case report and literature review. [PDF]

Front Immunol
Zhu GQ, Hu RX, Peng Y, Yao Y, Li GM.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians

Ca-A Cancer Journal for Clinicians, 2022
William A Hal, X Allen Li, Daniel A Low
exaly  

Oncologic emergencies and urgencies: A comprehensive review

Ca-A Cancer Journal for Clinicians, 2022
Bonnie Gould Rothberg, David E Gerber, Jason J Bischof   +2 more
exaly  

Genetic testing in prostate cancer management: Considerations informing primary care

Ca-A Cancer Journal for Clinicians, 2022
Veda N Giri, Jacob E Berchuck, Mary-Ellen Taplin   +2 more
exaly  

The oligometastatic spectrum in the era of improved detection and modern systemic therapy

Nature Reviews Clinical Oncology, 2022
Rohan Katipally, Steven J Chmura, Ralph R Weichselbaum   +2 more
exaly  

The mutational constraint spectrum quantified from variation in 141,456 humans

Nature, 2020
Konrad J Karczewski, Laurent C Francioli, Beryl B Cummings   +2 more
exaly